Terpenoids from cannabis strains enhanced the cancer cell-killing activity of THC or CBD, but only the terpenoids naturally co-produced with each cannabinoid in the same strain showed this synergy.
Cannabis breeders, product formulators, cancer researchers, and anyone interested in the entourage effect.
Strain-specific synergy
What the researchers found
Specific terpenoid groups were statistically associated with THC-rich or CBD-rich strains. Only terpenoids naturally co-occurring with a cannabinoid in the same strain enhanced its cytotoxic activity against breast and colon cancer cell lines. This effect was most potent when terpenoids were present in the natural ratios found in cannabis flower.
Why it matters
This provides some of the first scientific evidence for strain-specific entourage effects. It suggests that cannabis breeding has inadvertently selected for cannabinoid-terpenoid combinations that work together, and that mixing terpenoids randomly may not achieve the same synergy.
The numbers in context
17 cannabis strains profiled. Terpenoid-cannabinoid correlations identified statistically. Natural ratio combinations were most effective for cytotoxicity on MDA-MB-231 and HCT-116 cell lines.
How the study worked
Analytical profiling (HPLC, GC/MS) of secondary metabolites in 17 cannabis strains. Column separation of compounds. Cell viability assays on MDA-MB-231 (breast cancer) and HCT-116 (colon cancer) cell lines with various cannabinoid-terpenoid combinations.
What this study cannot tell us
In vitro cell line study only. Anti-cancer activity in a dish does not predict clinical efficacy. The mechanism of terpenoid-cannabinoid synergy was not identified. Limited to two cancer cell lines.
How to read the evidence
Preliminary: in vitro study with two cell lines, though with systematic strain profiling.
When this study was published
Published in 2019.
The bigger picture
If the entourage effect is strain-specific rather than universal, it has profound implications for cannabis product design. Simply adding terpenoids to isolates may not replicate the therapeutic effects of whole-plant extracts from specific strains.
Questions still open
- What molecular mechanism underlies strain-specific terpenoid-cannabinoid synergy? Does this strain specificity extend to therapeutic effects beyond cancer cell cytotoxicity?
Common questions
What is the entourage effect?
Does the cannabis strain matter for medical use?
Read the original research
Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity.
Molecules (Basel, Switzerland), 24(17)
Citation
Namdar, Dvora; Voet, Hillary; Ajjampura, Vinayaka; Nadarajan, Stalin; Mayzlish-Gati, Einav; Mazuz, Moran; Shalev, Nurit; Koltai, Hinanit. (2019). Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity.. Molecules (Basel, Switzerland), 24(17). https://doi.org/10.3390/molecules24173031
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk